The $12 central target is a calculated average of four current, attributed price targets rather than an official published consensus. The most recent verifiable targets are TD Cowen at $12 (Buy, maintained November 2026), Bernstein at $12.90 (initiated Outperform, October 2026), B. Riley Securities at $13 (Buy, raised from $12 in September 2026), and J.P. Morgan at $10 (Neutral, raised from $9 in September 2026). These average to $11.98, rounded to $12, with a range of roughly $10 to $13. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Some broader trackers that include older or less-current targets show averages closer to $11, but the four targets above represent the most recent individually verifiable views. The spread is meaningful: bullish analysts emphasize the Mytheresa platform's growth and the YNAP integration, while J.P. Morgan's Neutral stance reflects caution about whether operational progress converts quickly into durable profitability. Notably, J.P. Morgan briefly upgraded the stock to Overweight in February 2026 before downgrading back to Neutral within days after a corrected fully diluted share count reset how the company's earnings power is valued per share.
With shares near $10.75 and a 52-week range of $6.54 to $11.38, the stock sits close to its recent highs after a strong run (up roughly 27% year-to-date). Reaching $12 would require about 11.6% upside — a modest move — but it would also push the stock above its 52-week high and into record territory. The company generated roughly $2.5 billion in trailing revenue but remains unprofitable on a GAAP basis, with diluted EPS near negative $1.31 over the trailing twelve months. Because of those losses, the shares carry no meaningful P/E multiple, so investors are effectively valuing the turnaround story and future earnings power rather than current profitability.
The strongest tailwind is the Mytheresa–YNAP combination, which bulls argue creates a scaled, curated luxury e-commerce platform with meaningful cost and revenue synergies. Mytheresa is growing faster than the broader luxury market, and the company has posted consecutive quarters of positive adjusted EBITDA, signaling improving operating leverage. Recent analyst actions lean constructive: TD Cowen and B. Riley both raised targets in late 2026, and Bernstein launched coverage with an Outperform rating. Continued integration milestones, margin improvement, and a recovery in global luxury demand — particularly if China stabilizes — would all support a higher average analyst price target. From what I see, this integration remains the key variable to watch.
The principal obstacles are execution and demand. YOOX, the off-price segment, is loss-making with break-even targeted only around fiscal 2028, and integration costs continue to weigh on results. The company remains GAAP-loss-making, and the corrected fully diluted share count of roughly 140.1 million shares dilutes per-share earnings power. A softening luxury consumer backdrop, especially weakness among Chinese shoppers, could pressure growth. Finally, at $12 the stock would need to clear its prior 52-week high, and any disappointment in guidance or integration progress could compress the multiple investors are currently willing to pay for a money-losing business.
The $11.38 52-week high is the most relevant nearby level: it sits just above the current price and represents the first area of resistance the stock must clear before any sustained move toward $12. The $12 target itself sits above that prior high, meaning the move would require a breakout to new highs rather than a recovery within an established range. On the downside, the $9 to $10 zone has acted as a consolidation area through much of 2026 and coincides with J.P. Morgan's $10 target, offering a reference support level. The 52-week low of $6.54 marks the lower boundary of the multi-quarter range.
Analyst price targets generally reflect a research horizon of about 12 months, though firms do not always publish an explicit timeframe. Investors should watch the company's next quarterly report for revenue growth, adjusted EBITDA, and any update on YOOX's path to break-even. Also relevant are integration milestones, analyst target revisions, luxury-sector sales data, and central-bank rate decisions that affect high-end consumer spending. Changes to the share count or capital structure would also directly influence per-share valuation. I'm watching this closely as the next earnings release could shift sentiment.
In my analysis of names like LUXE, I find Tickeron's AI Daily Buy/Sell Signals helpful for layering technical insights onto the fundamental picture. The tool monitors market conditions and price behavior to surface opportunities and shifting trends, which can complement the review of analyst targets and integration progress here.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The Moving Average Convergence Divergence (MACD) for LUXE turned positive on November 03, 2026. Looking at past instances where LUXE's MACD turned positive, the stock continued to rise in 34 of 39 cases over the following month. The odds of a continued upward trend are 87%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on LUXE as a result. In 74 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
Following a +1.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where LUXE advanced for three days, in 183 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUXE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
LUXE broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for LUXE entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.166) is normal, around the industry mean (6.838). P/E Ratio (-8.492) is within average values for comparable stocks, (13.340). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.396). Dividend Yield (0.000) settles around the average of (0.110) among similar stocks. P/S Ratio (0.427) is also within normal values, averaging (2.867).
The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. LUXE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUXE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry CatalogSpecialtyDistribution